Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review.
Campi R, Berni A, Amparore D, Bertolo R, Capitanio U, Carbonara U, Erdem S, Ingels A, Kara O, Klatte T, Kriegmair M, Marchioni M, Minervini A, Mir MC, Papalia R, Pavan N, Pecoraro A, Gomez Rivas J, Rivasi G, Roussel E, Ungar A, Serni S, Esperto F; European Society of Residents in Urology (ESRU), EAU Young Academic Urologists (YAU) Renal Cancer Group. Campi R, et al. Among authors: marchioni m. Minerva Urol Nephrol. 2022 Apr;74(2):146-160. doi: 10.23736/S2724-6051.21.04583-3. Epub 2021 Oct 29. Minerva Urol Nephrol. 2022. PMID: 34714036 Free article.
Bladder neck contracture after surgery for benign prostatic obstruction.
Cindolo L, Marchioni M, Emiliani E, DE Francesco P, Primiceri G, Castellan P, Schips L. Cindolo L, et al. Among authors: marchioni m. Minerva Urol Nefrol. 2017 Apr;69(2):133-143. doi: 10.23736/S0393-2249.16.02777-6. Epub 2016 Dec 1. Minerva Urol Nefrol. 2017. PMID: 27905698 Free article. Review.
Effect of pathological high-risk features on cancer-specific mortality in non-metastatic clear cell renal cell carcinoma: a tool for optimizing patient selection for adjuvant therapy.
Bandini M, Smith A, Zaffuto E, Pompe RS, Marchioni M, Capitanio U, Chun FK, Kapoor AB, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI. Bandini M, et al. Among authors: marchioni m. World J Urol. 2018 Jan;36(1):51-57. doi: 10.1007/s00345-017-2093-6. Epub 2017 Oct 11. World J Urol. 2018. PMID: 29022072
Adjuvant Therapies in Nonmetastatic Renal-Cell Carcinoma: A Review of the Literature.
Bandini M, Smith A, Marchioni M, Pompe RS, Martel TF, Cindolo L, Montorsi F, Shariat SF, Briganti A, Kapoor A, Capitanio U, Karakiewicz PI. Bandini M, et al. Among authors: marchioni m. Clin Genitourin Cancer. 2018 Jun;16(3):176-183. doi: 10.1016/j.clgc.2018.01.003. Epub 2018 Feb 2. Clin Genitourin Cancer. 2018. PMID: 29449091 Review.
Comparison of Perioperative Outcomes Between Cytoreductive Radical Prostatectomy and Radical Prostatectomy for Nonmetastatic Prostate Cancer.
Preisser F, Mazzone E, Nazzani S, Bandini M, Tian Z, Marchioni M, Steuber T, Saad F, Montorsi F, Shariat SF, Huland H, Graefen M, Tilki D, Karakiewicz PI. Preisser F, et al. Among authors: marchioni m. Eur Urol. 2018 Dec;74(6):693-696. doi: 10.1016/j.eururo.2018.07.006. Epub 2018 Jul 20. Eur Urol. 2018. PMID: 30037529
255 results